The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 10.1% by 2035.
The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Supply Chain Disruptions Pose Market Challenges
Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.
What would be the Impact of US Trade Tariffs on the Global Clinical Trial Supply and Logistics for Pharma Market?
The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.
Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.
What Questions Should You Ask before Buying a Market Research Report?
- How is the clinical trial supply and logistics for pharma market evolving?
- What is driving and restraining the clinical trial supply and logistics for pharma market?
- How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
- How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2025 to 2035?
- What will be the main driver for the overall market from 2025 to 2035?
- Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
- Who are the leading players and what are their prospects over the forecast period?
- What are the clinical trial supply and logistics for pharma projects for these leading companies?
- How will the industry evolve during the period between 2025 and 2035? What are the implications of
- clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
- Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:
- Our 272-page report provides 115 tables and 129 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
- Forecasts to 2035 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
- Type
- CTS Manufacturing
- CTS Logistics & Distribution
- CT Supply Chain Management
- CTS Packaging & Storage
- Phase
- Preclinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Switzerland
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
- MEA
- GCC
- South Africa
- Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies' operations.
- Leading companies and the potential for market growth
- Almac Group
- Bilcare Limited
- Biocair
- Catalent, Inc.
- COREX Logistics
- Eurofins Scientific
- FedEx
- ICON plc
- Intertek Group plc
- Kerry Logistics Network Limited
- Kuehne+Nagel
- Marken (A UPS Company)
- Mayne Pharma Group Limited
- Movianto
- NAF Pharma
- Oximio
- Parexel International Corporation
- PCI Pharma Services (PCI)
- Royal Cargo
- Thermo Fisher Scientific Inc.
- United Parcel Service, Inc.
- Yourway
- Overall world revenue for Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 in terms of value the market will surpass US$16.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035.
- Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
- How will the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 report help you?
- In summary, our 270+ page report provides you with the following knowledge:
- Revenue forecasts to 2035 for Clinical Trial Supply and Logistics Market for Pharma 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035.
- Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
- Information found nowhere else
- With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.